Merck to buy Tilos Therapeutics in deal valued at up to $773 million
June 10, 2019 at 10:27 AM EDT
The proposed acquisition is Merck's second big deal in as many months.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|